LU86973A1 - Agent therapeutique pour le traitement des troubles associes a l'ischemie cerebrale - Google Patents
Agent therapeutique pour le traitement des troubles associes a l'ischemie cerebrale Download PDFInfo
- Publication number
- LU86973A1 LU86973A1 LU86973A LU86973A LU86973A1 LU 86973 A1 LU86973 A1 LU 86973A1 LU 86973 A LU86973 A LU 86973A LU 86973 A LU86973 A LU 86973A LU 86973 A1 LU86973 A1 LU 86973A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- cerebral
- treatment
- sequelae
- active ingredient
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19879686 | 1986-08-27 | ||
| JP19879686 | 1986-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU86973A1 true LU86973A1 (fr) | 1987-12-16 |
Family
ID=16397046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU86973A LU86973A1 (fr) | 1986-08-27 | 1987-08-26 | Agent therapeutique pour le traitement des troubles associes a l'ischemie cerebrale |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4870090A (es) |
| JP (1) | JPH07121863B2 (es) |
| KR (1) | KR950002151B1 (es) |
| AU (1) | AU603375B2 (es) |
| BE (1) | BE1003959A5 (es) |
| CA (1) | CA1302888C (es) |
| CH (1) | CH672069A5 (es) |
| DE (1) | DE3728499A1 (es) |
| DK (1) | DK171392B1 (es) |
| FI (1) | FI873727A (es) |
| FR (1) | FR2605222B1 (es) |
| GB (1) | GB2195532B (es) |
| HK (1) | HK64993A (es) |
| IE (1) | IE60601B1 (es) |
| IT (1) | IT1211477B (es) |
| LU (1) | LU86973A1 (es) |
| NL (1) | NL8701994A (es) |
| NO (1) | NO873571L (es) |
| NZ (1) | NZ221564A (es) |
| SE (1) | SE502323C2 (es) |
| SG (1) | SG52393G (es) |
| ZA (1) | ZA876401B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736529A (en) * | 1996-03-22 | 1998-04-07 | Neurocal International Inc. | Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration |
| US6329349B1 (en) * | 1997-10-23 | 2001-12-11 | Trustees Of The University Of Pennsylvania | Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents |
| AU4841700A (en) | 1999-05-12 | 2000-11-21 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
| CN107773545A (zh) * | 2016-08-29 | 2018-03-09 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1562962A (en) * | 1976-04-02 | 1980-03-19 | Chugai Pharmaceutical Co Ltd | Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same |
| US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
| WO1986006960A2 (en) * | 1985-05-22 | 1986-12-04 | Beecham Group P.L.C. | Use of nicorandil or pinacidil for the treatment of peripheral vascular disease |
| US4696934A (en) * | 1986-01-10 | 1987-09-29 | Warner-Lambert Company | Method for using nifedipine for treating stroke |
| WO1987005508A1 (en) * | 1986-03-14 | 1987-09-24 | Medical College Of Wisconsin Research Foundation, | Method of treatment and prevention of cerebral vasospasms |
-
1987
- 1987-08-19 IE IE221887A patent/IE60601B1/en not_active IP Right Cessation
- 1987-08-21 IT IT8767725A patent/IT1211477B/it active
- 1987-08-21 AU AU77311/87A patent/AU603375B2/en not_active Ceased
- 1987-08-24 US US07/089,044 patent/US4870090A/en not_active Expired - Lifetime
- 1987-08-24 NO NO873571A patent/NO873571L/no unknown
- 1987-08-25 DK DK441987A patent/DK171392B1/da not_active IP Right Cessation
- 1987-08-25 NZ NZ221564A patent/NZ221564A/xx unknown
- 1987-08-26 LU LU86973A patent/LU86973A1/fr unknown
- 1987-08-26 NL NL8701994A patent/NL8701994A/nl active Search and Examination
- 1987-08-26 DE DE19873728499 patent/DE3728499A1/de not_active Withdrawn
- 1987-08-26 CA CA000545418A patent/CA1302888C/en not_active Expired - Fee Related
- 1987-08-26 SE SE8703308A patent/SE502323C2/sv not_active IP Right Cessation
- 1987-08-26 FR FR878711957A patent/FR2605222B1/fr not_active Expired - Fee Related
- 1987-08-26 BE BE8700948A patent/BE1003959A5/fr not_active IP Right Cessation
- 1987-08-26 KR KR1019870009346A patent/KR950002151B1/ko not_active IP Right Cessation
- 1987-08-27 JP JP62213808A patent/JPH07121863B2/ja not_active Expired - Fee Related
- 1987-08-27 GB GB8720219A patent/GB2195532B/en not_active Expired - Fee Related
- 1987-08-27 ZA ZA876401A patent/ZA876401B/xx unknown
- 1987-08-27 FI FI873727A patent/FI873727A/fi not_active Application Discontinuation
- 1987-08-27 CH CH3298/87A patent/CH672069A5/de not_active IP Right Cessation
-
1993
- 1993-04-23 SG SG52393A patent/SG52393G/en unknown
- 1993-07-08 HK HK649/93A patent/HK64993A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB8720219D0 (en) | 1987-10-07 |
| NZ221564A (en) | 1999-08-30 |
| KR950002151B1 (ko) | 1995-03-14 |
| SE8703308L (sv) | 1988-02-28 |
| ZA876401B (en) | 1988-04-27 |
| NL8701994A (nl) | 1988-03-16 |
| BE1003959A5 (fr) | 1992-07-22 |
| FI873727A (fi) | 1988-02-28 |
| US4870090A (en) | 1989-09-26 |
| KR880002525A (ko) | 1988-05-09 |
| SE502323C2 (sv) | 1995-10-02 |
| GB2195532A (en) | 1988-04-13 |
| AU7731187A (en) | 1988-03-03 |
| DE3728499A1 (de) | 1988-03-03 |
| CH672069A5 (es) | 1989-10-31 |
| NO873571L (no) | 1988-02-29 |
| JPS63152317A (ja) | 1988-06-24 |
| NO873571D0 (no) | 1987-08-24 |
| FR2605222A1 (fr) | 1988-04-22 |
| GB2195532B (en) | 1990-05-23 |
| DK441987A (da) | 1988-02-28 |
| HK64993A (en) | 1993-07-16 |
| DK171392B1 (da) | 1996-10-14 |
| SE8703308D0 (sv) | 1987-08-26 |
| IT1211477B (it) | 1989-11-03 |
| IT8767725A0 (it) | 1987-08-21 |
| FI873727A0 (fi) | 1987-08-27 |
| IE60601B1 (en) | 1994-07-27 |
| DK441987D0 (da) | 1987-08-25 |
| SG52393G (en) | 1993-08-06 |
| IE872218L (en) | 1988-02-27 |
| FR2605222B1 (fr) | 1991-02-22 |
| AU603375B2 (en) | 1990-11-15 |
| CA1302888C (en) | 1992-06-09 |
| JPH07121863B2 (ja) | 1995-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001503737A (ja) | 糖尿病の発生を防止するためのシブトラミン類似体の利用 | |
| JP2001500883A (ja) | 低脂質値のためのシブトラミン類似物の使用 | |
| FR2896159A1 (fr) | Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline. | |
| FR2530468A1 (fr) | Composition analgesique et anti-inflammatoire contenant de l'ibuprofen | |
| EP0255415B1 (fr) | Utilisation de phényléthanolamines pour la préparation de médicaments agissant sur les troubles gastro-intestinaux | |
| FR2685918A1 (fr) | Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant. | |
| LU86973A1 (fr) | Agent therapeutique pour le traitement des troubles associes a l'ischemie cerebrale | |
| EP0738147A1 (fr) | Application du riluzole dans le traitement des maladies mitochondriales | |
| BE1009060A3 (fr) | Compositions pharmaceutiques et procede permettant leur preparation. | |
| FR2530470A1 (fr) | Composition comprenant un derive de vitamine d pour prevenir la fievre de lait chez la vache laitiere | |
| DE69307702T2 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
| EP1007522B1 (fr) | 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, sa preparation et son utilisation therapeutique | |
| FR2544614A1 (fr) | Nouvelle association medicamenteuse pour le traitement de l'hypertension | |
| BE1013314A3 (fr) | Agent stimulant la liberation d'acetylcholine dans le cerveau. | |
| JP3061445B2 (ja) | 血管拡張剤 | |
| JP7257091B2 (ja) | 認知症の治療及び予防薬 | |
| WO1998035670A1 (fr) | Produit contenant de l'idazoxan et de la 1-dopa comme preparation pharmaceutique combinee utilise pour la maladie de parkinson | |
| CH677731A5 (en) | Use of isoquinoline derivs. | |
| LU87777A1 (fr) | Nouvelle forme galenique orale ameliorant la biodisponibilite | |
| TW202337456A (zh) | Ｇｍ２神經節苷脂症之治療 | |
| JPH0645539B2 (ja) | 鎮痛剤 | |
| FR2624120A1 (fr) | Nouveaux sels organogermaniques utiles comme medicaments notamment comme activateurs des osteoblastes | |
| FR2787328A1 (fr) | Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures | |
| FR2460671A1 (fr) | Nouvelles compositions pharmaceutiques a base d'un derive de l'indole et d'une benzodiazepine | |
| FR2563731A1 (fr) | Composition therapeutique contenant de la 2-(n-phenylethyl-n-propylamino)-5-hydroxytetraline pour traiter la maladie de parkinson, pour stimuler selectivement les recepteurs de dopamine d-2 et procede de production d'une composition pharmaceutique utile au traitement de la maladie de parkinson |